Robertson JF - Search Results

1

Biological and clinical associations of c-jun activation in human breast cancer.

Gee JM, Barroso AF, Ellis IO, Robertson JF, Nicholson RI. Gee JM, et al. Among authors: robertson jf. Int J Cancer. 2000 Mar 20;89(2):177-86. doi: 10.1002/(sici)1097-0215(20000320)89:2<177::aid-ijc13>3.0.co;2-0. Int J Cancer. 2000. PMID: 10754497 Free article.

2

Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy.

Robertson JF, Dixon AR, Nicholson RI, Ellis IO, Elston CW, Blamey RW. Robertson JF, et al. Breast Cancer Res Treat. 1992;22(3):221-7. doi: 10.1007/BF01840835. Breast Cancer Res Treat. 1992. PMID: 1391988

3

Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment.

Low SC, Dixon AR, Bell J, Ellis IO, Elston CW, Robertson JF, Blamey RW. Low SC, et al. Among authors: robertson jf. Br J Surg. 1992 Dec;79(12):1314-6. doi: 10.1002/bjs.1800791224. Br J Surg. 1992. PMID: 1486427 Clinical Trial.

4

Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up.

Robertson JF, Ellis IO, Elston CW, Blamey RW. Robertson JF, et al. Eur J Cancer. 1992;28A(4-5):908-10. doi: 10.1016/0959-8049(92)90148-u. Eur J Cancer. 1992. PMID: 1524922 Clinical Trial.

5

Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.

Robertson JF, Bates K, Pearson D, Blamey RW, Nicholson RI. Robertson JF, et al. Br J Cancer. 1992 May;65(5):727-30. doi: 10.1038/bjc.1992.153. Br J Cancer. 1992. PMID: 1534019 Free PMC article.

6

Cellular effects of tamoxifen in primary breast cancer.

Robertson JF, Ellis IO, Nicholson RI, Robins A, Bell J, Blamey RW. Robertson JF, et al. Breast Cancer Res Treat. 1992 Jan;20(2):117-23. doi: 10.1007/BF01834641. Breast Cancer Res Treat. 1992. PMID: 1554887

7

Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.

Sacks NP, Robertson JF, Ellis IO, Nicholson RI, Crocker J, Blamey RW. Sacks NP, et al. Among authors: robertson jf. Eur J Surg Oncol. 1992 Apr;18(2):98-102. Eur J Surg Oncol. 1992. PMID: 1582518

8

An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast.

du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Robertson JF, Blamey RW. du Toit RS, et al. Among authors: robertson jf. Eur J Surg Oncol. 1991 Jun;17(3):251-7. Eur J Surg Oncol. 1991. PMID: 1646127 Clinical Trial.

9

c-erbB-2 oncoprotein expression in primary and advanced breast cancer.

Lovekin C, Ellis IO, Locker A, Robertson JF, Bell J, Nicholson R, Gullick WJ, Elston CW, Blamey RW. Lovekin C, et al. Among authors: robertson jf. Br J Cancer. 1991 Mar;63(3):439-43. doi: 10.1038/bjc.1991.101. Br J Cancer. 1991. PMID: 1672254 Free PMC article.

10

Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.

Galea MH, Athanassiou E, Bell J, Dilks B, Robertson JF, Elston CW, Blamey RW, Ellis IO. Galea MH, et al. Among authors: robertson jf. J Pathol. 1991 Nov;165(3):221-7. doi: 10.1002/path.1711650305. J Pathol. 1991. PMID: 1722247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

370 results

Search Page